Alexander Tennenbaum

Suggest Changes
Learn More
BACKGROUND Major randomized trials of fibrate therapy demonstrate an inverse relationship between on-treatment high-density lipoprotein cholesterol (HDL-C) increments and clinical outcome. We(More)
  • 1